The global vagus nerve stimulator market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases and rising demand for minimally invasive surgeries.
The direct vagus nerve stimulation segment accounted for the largest share in the global market in 2018, followed by percutaneous vagus nerve stimulation and hospital application segments. The direct vagus nerve stimulation segment is expected to maintain its dominance throughout the forecast period due to its ability to stimulate both afferent and efferent nerves simultaneously, which helps in treating various conditions such as epilepsy, depression, anxiety disorders, Parkinson’s disease etc, without any side effects or complications associated with other treatments.
North America accounted for the largest share in the global market in 2018 due to high adoption rates of new technologies among healthcare providers and patients across this region. Europe was a close second owing to increased awareness about new treatment options among patients suffering from chronic diseases such as epilepsy or depression etc, coupled with favorable reimbursement policies adopted by governments across this region that encourage adoption of these technologies among healthcare providers.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic diseases such as diabetes, obesity, and cardiovascular diseases are driving the growth of the Vagus Nerve Stimulators market.
- Increasing awareness about the benefits of VNS therapy for various conditions such as epilepsy, depression, and Parkinson's disease is also driving the growth of this market.
- The increasing number of clinical trials on VNS therapy for various conditions is also driving the growth in this market.
- The lack of reimbursement policies for these devices in many countries is a major restraint on this market.
Industry Growth Insights published a new data on “Vagus Nerve Stimulators Market”. The research report is titled “Vagus Nerve Stimulators Market research by Types (Direct Vagus Nerve Stimulation, Percutaneous Vagus Nerve Stimulation), By Applications (Hospital, Physical Examination Center, Medical College, Other), By Players/Companies BioControl Medical, Boston Scientific Corporation, CerboMed GmbH, Cerebral RX Ltd., Children's Hospital Boston, Cyberonics, DuoCure, ElectroCore, LLC, Medical University of South Carolina, MicroTransponder, Neurostream Technologies G.P., Setpoint Medical Corporation, Sorin S.p.A., Trifectas Medical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Vagus Nerve Stimulators Market Research Report
By Type
Direct Vagus Nerve Stimulation, Percutaneous Vagus Nerve Stimulation
By Application
Hospital, Physical Examination Center, Medical College, Other
By Companies
BioControl Medical, Boston Scientific Corporation, CerboMed GmbH, Cerebral RX Ltd., Children's Hospital Boston, Cyberonics, DuoCure, ElectroCore, LLC, Medical University of South Carolina, MicroTransponder, Neurostream Technologies G.P., Setpoint Medical Corporation, Sorin S.p.A., Trifectas Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Vagus Nerve Stimulators Market Report Segments:
The global Vagus Nerve Stimulators market is segmented on the basis of:
Types
Direct Vagus Nerve Stimulation, Percutaneous Vagus Nerve Stimulation
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Physical Examination Center, Medical College, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BioControl Medical
- Boston Scientific Corporation
- CerboMed GmbH
- Cerebral RX Ltd.
- Children's Hospital Boston
- Cyberonics
- DuoCure
- ElectroCore, LLC
- Medical University of South Carolina
- MicroTransponder
- Neurostream Technologies G.P.
- Setpoint Medical Corporation
- Sorin S.p.A.
- Trifectas Medical
Highlights of The Vagus Nerve Stimulators Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Direct Vagus Nerve Stimulation
- Percutaneous Vagus Nerve Stimulation
- By Application:
- Hospital
- Physical Examination Center
- Medical College
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vagus Nerve Stimulators Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Vagus nerve stimulators are medical devices that are used to treat conditions such as depression, anxiety, and chronic pain. These devices work by sending electrical impulses through the vagus nerve. This can help to improve symptoms related to these conditions.
Some of the key players operating in the vagus nerve stimulators market are BioControl Medical, Boston Scientific Corporation, CerboMed GmbH, Cerebral RX Ltd., Children's Hospital Boston, Cyberonics, DuoCure, ElectroCore, LLC, Medical University of South Carolina, MicroTransponder, Neurostream Technologies G.P., Setpoint Medical Corporation, Sorin S.p.A., Trifectas Medical.
The vagus nerve stimulators market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Vagus Nerve Stimulators Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Vagus Nerve Stimulators Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Vagus Nerve Stimulators Market - Supply Chain
4.5. Global Vagus Nerve Stimulators Market Forecast
4.5.1. Vagus Nerve Stimulators Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Vagus Nerve Stimulators Market Size (000 Units) and Y-o-Y Growth
4.5.3. Vagus Nerve Stimulators Market Absolute $ Opportunity
5. Global Vagus Nerve Stimulators Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Vagus Nerve Stimulators Market Size and Volume Forecast by Type
5.3.1. Direct Vagus Nerve Stimulation
5.3.2. Percutaneous Vagus Nerve Stimulation
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Vagus Nerve Stimulators Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Vagus Nerve Stimulators Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Physical Examination Center
6.3.3. Medical College
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Vagus Nerve Stimulators Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Vagus Nerve Stimulators Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Vagus Nerve Stimulators Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Vagus Nerve Stimulators Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Vagus Nerve Stimulators Demand Share Forecast, 2019-2026
9. North America Vagus Nerve Stimulators Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Vagus Nerve Stimulators Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Vagus Nerve Stimulators Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Physical Examination Center
9.4.3. Medical College
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Vagus Nerve Stimulators Market Size and Volume Forecast by Type
9.7.1. Direct Vagus Nerve Stimulation
9.7.2. Percutaneous Vagus Nerve Stimulation
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Vagus Nerve Stimulators Demand Share Forecast, 2019-2026
10. Latin America Vagus Nerve Stimulators Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Vagus Nerve Stimulators Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Vagus Nerve Stimulators Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Physical Examination Center
10.4.3. Medical College
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Vagus Nerve Stimulators Market Size and Volume Forecast by Type
10.7.1. Direct Vagus Nerve Stimulation
10.7.2. Percutaneous Vagus Nerve Stimulation
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Vagus Nerve Stimulators Demand Share Forecast, 2019-2026
11. Europe Vagus Nerve Stimulators Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Vagus Nerve Stimulators Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Vagus Nerve Stimulators Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Physical Examination Center
11.4.3. Medical College
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Vagus Nerve Stimulators Market Size and Volume Forecast by Type
11.7.1. Direct Vagus Nerve Stimulation
11.7.2. Percutaneous Vagus Nerve Stimulation
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o- Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Vagus Nerve Stimulators Demand Share, 2019-2026
12. Asia Pacific Vagus Nerve Stimulators Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Vagus Nerve Stimulators Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Vagus Nerve Stimulators Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Physical Examination Center
12.4.3. Medical College
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Vagus Nerve Stimulators Market Size and Volume Forecast by Type
12.7.1. Direct Vagus Nerve Stimulation
12.7.2. Percutaneous Vagus Nerve Stimulation
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Vagus Nerve Stimulators Demand Share, 2019-2026
13. Middle East & Africa Vagus Nerve Stimulators Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Vagus Nerve Stimulators Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Vagus Nerve Stimulators Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Physical Examination Center
13.4.3. Medical College
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Vagus Nerve Stimulators Market Size and Volume Forecast by Type
13.7.1. Direct Vagus Nerve Stimulation
13.7.2. Percutaneous Vagus Nerve Stimulation
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Vagus Nerve Stimulators Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Vagus Nerve Stimulators Market: Market Share Analysis
14.2. Vagus Nerve Stimulators Distributors and Customers
14.3. Vagus Nerve Stimulators Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BioControl Medical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. CerboMed GmbH
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cerebral RX Ltd.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Children's Hospital Boston
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Cyberonics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. DuoCure
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ElectroCore, LLC
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Medical University of South Carolina
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. MicroTransponder
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Neurostream Technologies G.P.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Setpoint Medical Corporation
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Sorin S.p.A.
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Trifectas Medical
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
